Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2003

01-12-2003 | Article

Strong Association Between Shiga Toxin-Producing Escherichia coli O157 and Virulence Genes stx 2 and eae as Possible Explanation for Predominance of Serogroup O157 in Patients with Haemolytic Uraemic Syndrome

Authors: D. Werber, A. Fruth, U. Buchholz, R. Prager, M. H. Kramer, A. Ammon, H. Tschäpe

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2003

Login to get access

Abstract

The aim of this study was to investigate the association between Shiga toxin-producing Escherichia coli (STEC) O157 and the simultaneous presence of the virulence genes stx 2 and eae in STEC from patients with gastroenteritis. In Germany, the proportion of serogroup O157 is substantially higher among STEC isolates from patients with haemolytic uraemic syndrome (HUS) than among STEC isolates from patients with gastroenteritis. The reason for this is unknown. Independent of serogroup, the virulence genes stx 2 and eae have been associated with severe disease. Data collected in 2000–2001 from a Germany-wide laboratory-based surveillance system for STEC-associated gastroenteritis in patients <15 years were analysed. Overall, 18% of the STEC isolates belonged to serogroup O157. Compared with non-O157 strains, 0157 isolates were strongly associated with the simultaneous presence of both an stx 2 gene and the eae gene (OR, 76; 95%CI, 27–230). Within the subset of STEC isolates that carried both virulence genes, 60% belonged to serogroup O157, a proportion similar to that found in STEC isolates from pediatric patients with HUS in Germany and Austria (67%, P=0.35). These data suggest that the more frequent carriage of both virulence genes, i.e. stx 2 and eae, forms the basis of why STEC O157 predominates in patients with HUS.
Literature
1.
go back to reference Gerber A, Karch H, Allerberger F, et al (2002) Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. J Infect Dis 186:493–500CrossRefPubMed Gerber A, Karch H, Allerberger F, et al (2002) Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. J Infect Dis 186:493–500CrossRefPubMed
2.
go back to reference Robert-Koch-Institut: Erkrankung durch enterohämorrhagische Escherichia coli Stämme (EHEC) (2001) In: RKI (ed) Infektionsepidemiologisches Jahrbuch meldefplichtiger Krankheiten für 2001. Mercedes-Druck, Berlin. pp 53 Robert-Koch-Institut: Erkrankung durch enterohämorrhagische Escherichia coli Stämme (EHEC) (2001) In: RKI (ed) Infektionsepidemiologisches Jahrbuch meldefplichtiger Krankheiten für 2001. Mercedes-Druck, Berlin. pp 53
3.
go back to reference Banatvala N, Griffin PM, Greene KD, et al (2001) The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063–1070CrossRefPubMed Banatvala N, Griffin PM, Greene KD, et al (2001) The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063–1070CrossRefPubMed
4.
go back to reference Fey PD, Wickert RS, Rupp ME, et al (2000) Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrhoeal stool samples from Nebraska. Emerg Infect Dis 6:530–533PubMed Fey PD, Wickert RS, Rupp ME, et al (2000) Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrhoeal stool samples from Nebraska. Emerg Infect Dis 6:530–533PubMed
5.
go back to reference Acheson DW, Frankson K, Willis D (1998) Multicenter prevalence study of Shiga toxin-producing Escherichia coli. In: Abstracts of the 98th General Meeting for the American Society for Microbiology. American Society for Microbiology, Washington DC, Abstract C-205 Acheson DW, Frankson K, Willis D (1998) Multicenter prevalence study of Shiga toxin-producing Escherichia coli. In: Abstracts of the 98th General Meeting for the American Society for Microbiology. American Society for Microbiology, Washington DC, Abstract C-205
6.
go back to reference Cornick NA, Jelacic S, Ciol MA, et al (2002) Escherichia coli O157:H7 infections: discordance between filterable fecal Shiga toxin and disease outcome. J Infect Dis 186:57–63PubMed Cornick NA, Jelacic S, Ciol MA, et al (2002) Escherichia coli O157:H7 infections: discordance between filterable fecal Shiga toxin and disease outcome. J Infect Dis 186:57–63PubMed
7.
go back to reference Louise CB, Obrig TG (1995) Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 172:1397–1401 Louise CB, Obrig TG (1995) Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 172:1397–1401
8.
go back to reference Tesh VL, Burris JA, Owens JW, et al (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392–3402PubMed Tesh VL, Burris JA, Owens JW, et al (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392–3402PubMed
9.
go back to reference Barrett TJ, Potter ME, Strockbine NA (1990) Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice. Microb Pathog 9:95–103PubMed Barrett TJ, Potter ME, Strockbine NA (1990) Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice. Microb Pathog 9:95–103PubMed
10.
go back to reference Siegler RL, Obrig TG, Pysher TJ, et al (2003) Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92–96PubMed Siegler RL, Obrig TG, Pysher TJ, et al (2003) Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92–96PubMed
11.
go back to reference Ostroff SM, Tarr PI, Neill MA, et al (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 160:994–998PubMed Ostroff SM, Tarr PI, Neill MA, et al (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 160:994–998PubMed
12.
go back to reference Boerlin P, McEwen SA, Boerlin-Petzold F, et al (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37:497–503PubMed Boerlin P, McEwen SA, Boerlin-Petzold F, et al (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37:497–503PubMed
13.
go back to reference Zimmerhackl LB (2003) Epidemiology of haemolytic uraemic syndrome in childhood. In: Abstracts of the 5th International Symposium on Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infections, Edinburgh, Abstract O46 Zimmerhackl LB (2003) Epidemiology of haemolytic uraemic syndrome in childhood. In: Abstracts of the 5th International Symposium on Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infections, Edinburgh, Abstract O46
14.
go back to reference Werber D, Ammon A (2000) Development of a research network for emerging foodborne pathogens in Germany. Euro Surveill 5:120–123PubMed Werber D, Ammon A (2000) Development of a research network for emerging foodborne pathogens in Germany. Euro Surveill 5:120–123PubMed
15.
go back to reference Fruth A, Richter H, Timm M, et al (2000) Zur Verbesserung der gegenwärtigen bakteriologischen Diagnostik von enterohämorrhagischen Escherichia coli (EHEC). Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 43:310–317 Fruth A, Richter H, Timm M, et al (2000) Zur Verbesserung der gegenwärtigen bakteriologischen Diagnostik von enterohämorrhagischen Escherichia coli (EHEC). Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 43:310–317
16.
go back to reference Ørskov F, Ørskov I (1984) Serotyping of Escherichia coli. Methods Microbiol 14:43–112 Ørskov F, Ørskov I (1984) Serotyping of Escherichia coli. Methods Microbiol 14:43–112
17.
go back to reference Cebula TA, Payne WL, Feng P (1995) Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J Clin Microbiol 33:248–250PubMed Cebula TA, Payne WL, Feng P (1995) Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J Clin Microbiol 33:248–250PubMed
18.
go back to reference Schmidt H, Russmann H, Karch H (1993) Virulence determinants in nontoxinogenic Escherichia coli O157 strains that cause infantile diarrhea. Infect Immun 61:4894–4898PubMed Schmidt H, Russmann H, Karch H (1993) Virulence determinants in nontoxinogenic Escherichia coli O157 strains that cause infantile diarrhea. Infect Immun 61:4894–4898PubMed
19.
go back to reference Beutin L, Geier D, Zimmermann S, et al (1995) Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J Clin Microbiol 33:631–635PubMed Beutin L, Geier D, Zimmermann S, et al (1995) Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J Clin Microbiol 33:631–635PubMed
20.
go back to reference Willshaw GA, Scotland SM, Smith HR, et al (1992) Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis 166:797–802PubMed Willshaw GA, Scotland SM, Smith HR, et al (1992) Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis 166:797–802PubMed
21.
go back to reference Coimbra RS, Grimont F, Lenormand P, et al (2000) Identification of Escherichia coli O-serogroups by restriction of the amplified O-antigen gene cluster (rfb-RFLP). Res Microbiol 151:639–654CrossRefPubMed Coimbra RS, Grimont F, Lenormand P, et al (2000) Identification of Escherichia coli O-serogroups by restriction of the amplified O-antigen gene cluster (rfb-RFLP). Res Microbiol 151:639–654CrossRefPubMed
22.
go back to reference Eklund M, Leino K, Siitonen A (2002) Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles. J Clin Microbiol 40:4585–4593CrossRefPubMed Eklund M, Leino K, Siitonen A (2002) Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles. J Clin Microbiol 40:4585–4593CrossRefPubMed
23.
go back to reference Karch H, Schmidt H, Brunder W (1998) Plasmid-encoded determinants of Escherichia coli O157:H7. In: Kaper JB, O’Brien A (eds) Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington DC, pp 183–194 Karch H, Schmidt H, Brunder W (1998) Plasmid-encoded determinants of Escherichia coli O157:H7. In: Kaper JB, O’Brien A (eds) Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington DC, pp 183–194
24.
go back to reference Friedrich AW, Bielaszewska M, Zhang WL, et al (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185:74–84PubMed Friedrich AW, Bielaszewska M, Zhang WL, et al (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185:74–84PubMed
Metadata
Title
Strong Association Between Shiga Toxin-Producing Escherichia coli O157 and Virulence Genes stx 2 and eae as Possible Explanation for Predominance of Serogroup O157 in Patients with Haemolytic Uraemic Syndrome
Authors
D. Werber
A. Fruth
U. Buchholz
R. Prager
M. H. Kramer
A. Ammon
H. Tschäpe
Publication date
01-12-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-1025-0

Other articles of this Issue 12/2003

European Journal of Clinical Microbiology & Infectious Diseases 12/2003 Go to the issue

Contributing Reviewers

Reviewers in 2003

Announcements

December 2003

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.